Cost Analysis of Robot-Assisted Versus On-Pump and Off-Pump Coronary Artery Bypass Grafting: A Single-Center Surgical and 30-Day Outcomes Comparison
Authors:
Open Access
- 1 July 2024
- journal article
- research article
- Published by SAGE Publications in Innovations: Technology and Techniques in Cardiothoracic and Vascular Surgery
- Vol. 19 (4) , 416-424
Abstract
Objective: Throughout Europe, the interest in implementing robot-assisted minimally invasive direct coronary artery bypass (RA-MIDCAB) has been growing. However, concerns about additional costs have emerged concurrently. In this analysis, we aim to provide a comparison of the cumulative perioperative costs of RA-MIDCAB, on-pump coronary artery bypass grafting (CABG), and off-pump CABG (OPCAB). Methods: We conducted a propensity score–matched analysis comparing patients undergoing RA-MIDCAB with those undergoing CABG or OPCAB at our institution from January 2016 to December 2021. After matching, we analyzed the combined intraoperative surgical costs and 30-day postoperative costs. We first compared RA-MIDCAB costs to CABG and then to OPCAB separately. Violin plots illustrated the cost distribution among individual patients. Total cost uncertainty was estimated using 1,000 bootstrapping iterations. Results: Seventy-nine RA-MIDCAB patients were matched to 158 CABG patients, and 80 RA-MIDCAB patients were matched to 149 OPCAB patients. Considering both surgical and clinical outcomes, RA-MIDCAB yielded an average cost of €17,121 per patient (€16,781 to €33,294), CABG was €16,571 per patient (€16,664 to €41,860), and OPCAB was €15,463 per patient (€10,895 to €57,867). After bootstrap iterations, RA-MIDCAB was found to be €472 (2.8%) and €1,599 (10.3%) more expensive per patient than CABG and OPCAB, respectively. Conclusions: In The Netherlands, the adoption of RA-MIDCAB did not show a significant economic impact on hospital resources. The additional robotic costs for the surgery were almost entirely offset by the cost savings during the postoperative hospital stay. However, these comparisons may differ when considering hybrid coronary revascularization with its additional percutaneous coronary intervention costs.Keywords
This publication has 18 references indexed in Scilit:
- Early home discharge after robot-assisted coronary artery bypass graftingInteractive CardioVascular and Thoracic Surgery, 2022
- Minimally invasive surgery or stenting for left anterior descending artery disease – meta-analysisIJC Heart & Vasculature, 2022
- Cost-effectiveness analysis of a multicentre randomized clinical trial comparing surgery with conservative management for recurrent and ongoing diverticulitis (DIRECT trial)British Journal of Surgery, 2018
- 2018 ESC/EACTS Guidelines on myocardial revascularizationEuropean Heart Journal, 2018
- Cost of individual complications following coronary artery bypass graftingThe Journal of Thoracic and Cardiovascular Surgery, 2018
- Robotic Total Arterial Off-Pump Coronary Artery Bypass Grafting: Seven-Year Single-Center Experience and Long-Term Follow-Up of Graft PatencyThe Annals of Thoracic Surgery, 2015
- The Impact of Hybrid Coronary Revascularization on Hospital Costs and ReimbursementsThe Annals of Thoracic Surgery, 2014
- Early clinical and angiographic outcomes after robotic-assisted coronary artery bypass surgeryThe Journal of Thoracic and Cardiovascular Surgery, 2014
- A comparison of 12 algorithms for matching on the propensity scoreStatistics in Medicine, 2013
- New Technology and Health Care Costs — The Case of Robot-Assisted SurgeryNew England Journal of Medicine, 2010